86 related articles for article (PubMed ID: 20804054)
1. [Low-molecular DNA in blood plasma and spinal fluid of cancer patients].
Vladimirov VG; Sharova LA
Vopr Onkol; 2010; 56(3):317-20. PubMed ID: 20804054
[TBL] [Abstract][Full Text] [Related]
2. Cytology of cerebrospinal fluid in the diagnosis of malignancy.
el-Batata M
J Neurosurg; 1968 Apr; 28(4):317-26. PubMed ID: 4296167
[No Abstract] [Full Text] [Related]
3. [Brain metastasis and the carcinoembryonic antigen].
Noris-García E; Escobar-Pérez X
Rev Neurol; 2004 Feb 1-15; 38(3):267-70. PubMed ID: 14963857
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid and serum carcinoembryonic antigen in brain tumors.
Batabyal SK; Ghosh B; Sengupta S; Ghosh SN; Chatterjee R
Neoplasma; 2003; 50(5):377-9. PubMed ID: 14628092
[TBL] [Abstract][Full Text] [Related]
5. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.
Paci M; Maramotti S; Bellesia E; Formisano D; Albertazzi L; Ricchetti T; Ferrari G; Annessi V; Lasagni D; Carbonelli C; De Franco S; Brini M; Sgarbi G; Lodi R
Lung Cancer; 2009 Apr; 64(1):92-7. PubMed ID: 18804892
[TBL] [Abstract][Full Text] [Related]
6. Integrity of cell-free plasma DNA in patients with lung cancer and nonmalignant lung disease.
Schmidt B; Weickmann S; Witt C; Fleischhacker M
Ann N Y Acad Sci; 2008 Aug; 1137():207-13. PubMed ID: 18837948
[TBL] [Abstract][Full Text] [Related]
7. Extracellular DNA in breast cancer: Cell-surface-bound, tumor-derived extracellular DNA in blood of patients with breast cancer and nonmalignant tumors.
Rykova EY; Laktionov PP; Skvortsova TE; Starikov AV; Kuznetsova NP; Vlassov VV
Ann N Y Acad Sci; 2004 Jun; 1022():217-20. PubMed ID: 15251963
[TBL] [Abstract][Full Text] [Related]
8. [Plasma DNA level as a tumor marker in primary lung cancer].
Maebo A
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Aug; 28(8):1085-91. PubMed ID: 2243459
[TBL] [Abstract][Full Text] [Related]
9. Tumor DNA in plasma at diagnosis of breast cancer patients is a valuable predictor of disease-free survival.
Silva JM; Silva J; Sanchez A; Garcia JM; Dominguez G; Provencio M; Sanfrutos L; Jareño E; Colas A; España P; Bonilla F
Clin Cancer Res; 2002 Dec; 8(12):3761-6. PubMed ID: 12473587
[TBL] [Abstract][Full Text] [Related]
10. The cytopathology of cerebrospinal fluid. II. Metastatic cancer, meningeal carcinomatosis and primary central nervous system neoplasms.
Bigner SH; Johnston WW
Acta Cytol; 1981; 25(5):461-79. PubMed ID: 7025541
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of free DNA quantification in serum and cerebrospinal fluid in glioma patients.
Shi W; Lv C; Qi J; Zhao W; Wu X; Jing R; Wu X; Ju S; Chen J
J Mol Neurosci; 2012 Mar; 46(3):470-5. PubMed ID: 21881830
[TBL] [Abstract][Full Text] [Related]
12. Cytopathology of nonlymphoreticular neoplasms metastatic to the central nervous system.
Ehya H; Hajdu SI; Melamed MR
Acta Cytol; 1981; 25(6):599-610. PubMed ID: 6947665
[TBL] [Abstract][Full Text] [Related]
13. Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up?
Bremnes RM; Sirera R; Camps C
Lung Cancer; 2005 Jul; 49(1):1-12. PubMed ID: 15949585
[TBL] [Abstract][Full Text] [Related]
14. Extracellular tumor DNA in plasma and overall survival in breast cancer patients.
Garcia JM; Garcia V; Silva J; Peña C; Dominguez G; Sanchez A; Sanfrutos L; Provencio M; Millan I; Chaparro D; España P; Bonilla F
Genes Chromosomes Cancer; 2006 Jul; 45(7):692-701. PubMed ID: 16607614
[TBL] [Abstract][Full Text] [Related]
15. Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) detection in cancer patients: a prognostic marker for lung metastases from solid malignancies.
Karapanagiotou EM; Pelekanou E; Charpidou A; Tsaganos T; Anagnostou V; Plachouras D; Giamarellos-Bourboulis EJ; Syrigos KN
Anticancer Res; 2008; 28(2B):1411-5. PubMed ID: 18505088
[TBL] [Abstract][Full Text] [Related]
16. RNA is more sensitive than DNA in identification of breast cancer patients bearing tumor nucleic acids in plasma.
Silva J; Silva JM; García V; García JM; Domínguez G; Bonilla F
Genes Chromosomes Cancer; 2002 Dec; 35(4):375-6. PubMed ID: 12378534
[No Abstract] [Full Text] [Related]
17. Microsatellite alterations plasma DNA of primary breast cancer patients.
Shaw JA; Smith BM; Walsh T; Johnson S; Primrose L; Slade MJ; Walker RA; Coombes RC
Clin Cancer Res; 2000 Mar; 6(3):1119-24. PubMed ID: 10741742
[TBL] [Abstract][Full Text] [Related]
18. Reproducibility of a semiquantitative measurement of circulating DNA in plasma from neoplastic patients.
Frattini M; Balestra D; Verderio P; Gallino G; Leo E; Sozzi G; Pierotti MA; Daidone MG
J Clin Oncol; 2005 May; 23(13):3163-4; author reply 3164-5. PubMed ID: 15860889
[No Abstract] [Full Text] [Related]
19. Circulating deoxyribonucleic Acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy.
Gautschi O; Bigosch C; Huegli B; Jermann M; Marx A; Chassé E; Ratschiller D; Weder W; Joerger M; Betticher DC; Stahel RA; Ziegler A
J Clin Oncol; 2004 Oct; 22(20):4157-64. PubMed ID: 15483026
[TBL] [Abstract][Full Text] [Related]
20. Circulating tumour-derived predictive biomarkers in oncology.
Hodgson DR; Wellings R; Orr MC; McCormack R; Malone M; Board RE; Cantarini MV
Drug Discov Today; 2010 Feb; 15(3-4):98-101. PubMed ID: 20045486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
